Vladonix

Used in bioregulator stacks

Manufacturer-style organ combinations - not FDA protocols. Every name is a live leaf.

• Cardiovascular & heartTarget: Heart + vesselsOpen stack →
• RespiratoryTarget: LungsOpen stack →
• Immune systemTarget: Thymus + pineal + marrow + gutOpen stack →

The Khavinson school

Vladimir Khatskelevich Khavinson (1946–2024) spent five decades at what became the St. Petersburg Institute of Bioregulation and Gerontology arguing a simple, stubborn idea: aging is, in part, a failure of tissue-specific peptide signals, and those signals can be restored. The first products were not “peptides” in the Instagram sense. They were Cytamins - polypeptide fractions isolated from a named organ of young animals. Later commercial refinements of those fractions are sold as Cytomaxes (Cytomed / NPCRIZ): still mixtures, still oral capsules, still defined by the source organ rather than a single sequence. When the group identified short active motifs inside those mixtures, they synthesized them as Cytogens - di-, tri-, and tetrapeptides with a one-letter code (KE, AEDG, KED, EDR, KEDP, and so on).

That three-layer stack is the whole map. Cytamin / pharmaceutical extracts (Thymalin, Epithalamin, Cortexin, Retinalamin, Prostatilen) are the clinic-era injectables registered in the former Soviet pharmacopeia. Cytomaxes are the capsule complexes Cytomed still lists as a 21-SKU organ line. Cytogens are the defined synthetics. English-language educators, including Brenden Henry’s public writing at Peptide Science Institute, add a further commercial distinction - later analog SKUs (N-acetyl, amidate, “V2” complexes) sold as more stable or more diverse than the original Cytomed lots. That last layer is a product taxonomy, not a Khavinson paper. We describe it so readers are not gaslit by three bottles with the same organ name. We do not reproduce paid Peptide Mastery protocols, Precision Cell Method language, or anyone else’s course IP.

Public English-language teaching (including Brenden Henry at peptidescienceinstitute.com) is cited as context, not copied. Paid Peptide Mastery / Peptide Salvation text stays theirs.

History of this molecule

The thymus is Khavinson’s other flagship organ, because it involutes on a schedule every mammal knows. Soviet peptide gerontology treated thymic extracts as a way to keep T-cell education from collapsing with age. Thymalin is the pharmaceutical extract that actually has a long clinical footprint in Russia. Vladonix is the Cytomax capsule complex from the same organ.

Western peptide Twitter collapsed “thymic peptide” into Thymosin Alpha-1 (Zadaxin) or TB-500. Those are different molecules, different developers, different regulatory stories. Khavinson’s thymic line is tissue-specific short peptides and extracts - KE (Vilon), EW (Thymogen), EDP (Crystagen), plus the complex. Mixing TA1 papers into a Vladonix page is how you get a fake evidence stack.

The Institute’s pairing is explicit on the NPCRIZ map: Vladonix (complex) with the immune cytogens. Crystagen is the broad immunocompetent-cell cytogen - not a colon peptide, despite a bad Western catalog that still says “gut.” If a page on this site ever said colon, that was a bug. The organ is immune/thymus.

Khavinson and Morozov’s early extract work on thymic peptides is the historical layer. The 15-year Thymalin + Epitalon mortality follow-ups that English blogs love are extract/synthetic combination data, not a Vladonix capsule trial in Florida.